Veterans Evaluation Services (VES, Maximus VA MDE Subsidiary)
nodeAI & Compute
One company grabbed billions in federal contracts to run the medical exams that decide veterans' disability benefits.
Who they are
Veterans Evaluation Services (VES), a subsidiary of Maximus Inc.
What they do
The engine reads it as a dominant but not sole player in the federal veterans' disability-exam market.
How it works
It captured $3.7 billion of $12 billion obligated on a $13.2 billion federal contract vehicle for VA disability exams, holding about 30.8% market share in a four-company oligopoly. Demand surged after the 2022 PACT Act expanded benefits, and Maximus is investing in AI startups to handle the exam workload more cheaply.
Why it matters
It matters as a clear example that Maximus isn't a pure monopoly across all federal services, but a major node in a market shared by a handful of incumbents.
The engine's record — word for word
Report #86. Maximus Inc subsidiary capturing $3.7B of $12B obligated on the $13.2B IDIQ vehicle for Department of Veterans Affairs Medical Disability Exams (MDE). Market surged by the 2022 PACT Act expansion of VA disability benefits coverage, which dramatically increased required clinical exam scheduling throughput. ~30.8% market share — operates as a major node in a 4-incumbent oligopoly (VES + Leidos/QTC $5.1B + UnitedHealthcare/OptumServe $3.4B + Loyal Source). Substitutability friction 12-18 months. Maximus Ventures is investing in human-in-the-loop AI startups specifically targeting VES's clinical-assessment workload for margin expansion against stagnant federal labor caps. The VA MDE oligopoly is the second clearest example (alongside ED servicers) that Maximus does not constitute a pure monopoly across all federal-services vectors.
Follow the trail
Walk this on the live map →